Tag:
OncoVex
Latest Headlines
Latest Headlines
Amgen bets $1B on BioVex's dual-mechanism cancer therapy
In a bold late-stage gamble, Amgen has agreed to pay $425 million in cash to license a promising cancer vaccine from Woburn, MA-based BioVex , a 2009 Fierce 15 company which migrated to the U.S.
BioVex snags $30M to pay for pivotal trial
A week after putting out the final data on its successful mid-stage cancer trial for OncoVex, BioVex has fattened its bank account with $30 million in fresh venture funds from a slate of new
BioVex CEO upbeat on OncoVex data, hints at a deal
BioVex has dotted the i's and crossed the t's on its Phase II data for OncoVex, adding another complete responder to its tally of advanced melanoma patients who reacted favorably to its OncoVex
